The weekly roundup

November 24, 2016 | Pamela Youngberg Dickson

On Tuesday, the Journal of the American Medical Association released results from a study on adverse drug events. The study examined nearly 42,600 cases from the National Electronic Injury Surveillance System — Cooperative Adverse Drug Event Surveillance project and found, in part, that the rate of ER visits of adults aged 65 years and older was three times that of those 65 and younger (9.7 visits per 1,000 individuals compared with 3.1, respectively.) Dig into more of the highlights in this Pharmalot story from Ed Silverman. According to the CDC, 11.9 percent of ER visits result in hospital admissions. It’s certainly not a brand new story, but it does highlight the opportunity for pharmacists to better engage with physicians and patients as a valuable part of the care team.

Continue reading →

Upping the ante on diabetes care

November 18, 2016 | Pamela Youngberg Dickson

On November 2, Medicare released its final rule solidifying its focus on chronic care management and behavioral health, including a plan to expand the Diabetes Prevention Program model test in 2018. Medicare estimates it will spend $42 billion on fee-for-service, non-dual-eligible beneficiaries with diabetes, and the program encourages the establishment of community-based intervention to prevent and manage the disease in an effort to bring those costs down. 

Diabetes is a high driver of health care costs and is one of the most prevalent chronic conditions seen in our independent pharmacies. It’s also one of the five disease states plans are most focused upon this year and for the foreseeable future. Here’s why focusing on diabetes care is important:

Continue reading →